| abstract |
The salts are inhibitors of re-uptake of monoamine neurotransmitters. In other aspects, the present is related to the use of these salts in a therapy method and with pharmaceutical compositions that include the salts of the present. Claim 1: A salt selected from the anhydrous and hydrated forms of tartrate of (1R, 2R, 3S, 5S) -2-methoxymethyl-3- (3,4-dichlorophenyl) -8-azabicyclo [3,2,1] octane . |